Invited, % | Cut-off 10-year QRisk threshold above which patients are invited | Extra cost, £ | QALY gain | Incremental cost-effectiveness ratio, £ | Net benefit, £b | Probability highest net benefit, % |
---|---|---|---|---|---|---|
0 | 0 | 0 | 0.00 | 0 | 0 | 3.9 |
2 | 0.2027 | 18 553 | 6.96 | 2666 | 120 624 | 11.2 |
4 | 0.1667 | 59 689 | 11.26 | 9567 | 165 497 | 12.0 |
6 | 0.1445 | 109 248 | 14.68 | 14 491 | 184 360 | 10.2 |
8 | 0.1277 | 162 280 | 17.53 | 18 608 | 188 397 | 8.3 |
10 | 0.1142 | 215 722 | 19.89 | 22 645 | 181 994 | 6.7 |
13 | 0.0983 | 278 487 | 22.39 | 25 106 | 169 308 | 4.7 |
15 | 0.0896 | 298 686 | 23.32 | 21 719 | 167 641 | 4.6 |
20 | 0.0721 | 323 632 | 24.87 | 16 094 | 173 820 | 7.3 |
25 | 0.0590 | 343 949 | 26.08 | 16 791 | 177 566 | 7.6 |
30 | 0.0488 | 364 684 | 26.99 | 22 786 | 175 200 | 6.9 |
35 | 0.0406 | 386 548 | 27.76 | 28 395 | 168 666 | 6.0 |
40 | 0.0339 | 409 016 | 28.38 | 36 239 | 158 551 | 4.2 |
45 | 0.0283 | 431 764 | 28.86 | 47 392 | 145 452 | 3.2 |
50 | 0.0236 | 455 915 | 29.23 | 65 273 | 128 648 | 1.6 |
55 | 0.0197 | 480 422 | 29.51 | 87 525 | 107 797 | 1.0 |
60 | 0.0163 | 505 461 | 29.74 | 108 865 | 89 378 | 0.4 |
70 | 0.0110 | 555 955 | 30.04 | 168 313 | 44 747 | 0.2 |
80 | 0.0071 | 606 743 | 30.21 | 298 753 | −2536 | 0.01 |
90 | 0.0041 | 656 963 | 30.30 | 558 000 | −51 029 | 0.00 |
95 | 0.0028 | 681 608 | 30.31 | 2 464 500 | −75 370 | 0.00 |
100 | 0.0006 | 705 732 | 30.32 | 2 412 400 | −99 430 | 0.00 |